(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MODULADORES DE EXPRESSÃO DE ENAC

ArquivadaInvention PatentPCT · US2018058354

Application data

Number

112020005038

Type

Invention Patent

Filing

10/31/2018

Publication

09/15/2020

PCT

US2018058354

Progress at the INPI

  1. Filing10/31/18
  2. Publication09/15/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 11/22/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

IONIS PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

A. W. (pessoa física)

US

H. B. (pessoa física)

US

J. C. (pessoa física)

US

S. G. (pessoa física)

US

S. F. (pessoa física)

US

Technical data

Priority claims

US

62/579,640 · 10/31/2017

US

62/743,669 · 10/10/2018

Abstract

As presentes modalidades fornecem métodos, compostos e composições úteis para inibir a expressão de ENaC, que podem ser úteis para tratar, prevenir ou melhorar uma doença associada ao ENaC.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

11/22/2022

RPI 2707

Parecer de pré-exame

#6.23

08/16/2022

RPI 2693

Adição na publicação

#15.35

11/23/2021

RPI 2655

Notificação de entrada na fase nacional - PCT

#1.3

09/15/2020

RPI 2593

Alteração de dados cadastrais

#1.1

03/24/2020

RPI 2568

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.